ADJUVANT CHEMOTHERAPY IN HIGH RISK BREAST CANCER PATIENTS

  • Blum, Ronald (PI)
  • Hochster, Howard S. (PI)

Project Details

Description

This study will compare disease-free survival, overall survival and toxicity of high-risk primary breast cancer patients with negative axillary lymph nodes or with one to three positive nodes treated with adjuvant high-dose chemotherapy with doxorubicin plus cyclophosphamide, versus high-dose sequential chemotherapy with doxorubicin followed by cyclophosphamide.
StatusFinished
Effective start/end date1/10/9530/09/99

Funding

  • National Center for Research Resources

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.